Lecap Asset Management LTD Alnylam Pharmaceuticals, Inc. Transaction History
Lecap Asset Management LTD
- $283 Billion
- Q2 2025
A detailed history of Lecap Asset Management LTD transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Lecap Asset Management LTD holds 1,985 shares of ALNY stock, worth $863,673. This represents 0.23% of its overall portfolio holdings.
Number of Shares
1,985
Previous 1,709
16.15%
Holding current value
$863,673
Previous $461 Million
40.27%
% of portfolio
0.23%
Previous 0.11%
Shares
3 transactions
Others Institutions Holding ALNY
# of Institutions
746Shares Held
110MCall Options Held
966KPut Options Held
841K-
Capital World Investors Los Angeles, CA16.7MShares$7.29 Billion0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$5.68 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$4.15 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.15MShares$3.11 Billion0.44% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.42MShares$1.92 Billion0.79% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $53.5B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...